{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T01:36:02Z","timestamp":1768527362732,"version":"3.49.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"2-3","license":[{"start":{"date-parts":[[2004,6,1]],"date-time":"2004-06-01T00:00:00Z","timestamp":1086048000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2004,6]]},"DOI":"10.1016\/j.ejps.2004.03.007","type":"journal-article","created":{"date-parts":[[2004,5,11]],"date-time":"2004-05-11T10:36:08Z","timestamp":1084271768000},"page":"209-216","source":"Crossref","is-referenced-by-count":10,"title":["Pharmacokinetic interactions between phenylpropanolamine, caffeine and chlorpheniramine in rats"],"prefix":"10.1016","volume":"22","author":[{"given":"Amal","family":"Kaddoumi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mihoko N","family":"Nakashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuhiro","family":"Wada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichiro","family":"Nakashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2004.03.007_BIB1","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/clpt.1991.152","article-title":"A pharmacodynamic interaction between caffeine and phenylpropanolamine","volume":"50","author":"Brown","year":"1991","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2004.03.007_BIB2","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2165\/00003088-200039020-00004","article-title":"Clinically significant pharmacokinetic interactions between dietary caffeine and medications","volume":"39","author":"Carrillo","year":"2000","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejps.2004.03.007_BIB3","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1126\/science.211589","article-title":"Presynaptic alpha-receptor subsensitivity after long-term antidepressant treatment","volume":"202","author":"Crews","year":"1978","journal-title":"Science"},{"key":"10.1016\/j.ejps.2004.03.007_BIB4","unstructured":"FDA Letter to Manufacturers of Drug Products Containing Phenylpropanolamine (PPA), 2000. http:\/\/www.fda.gov\/cder\/drug\/infopage\/ppa\/ppaltr.htm."},{"key":"10.1016\/j.ejps.2004.03.007_BIB5","doi-asserted-by":"crossref","unstructured":"Gibaldi, M., Perrier, M., 1982. Pharmacokinetics, 2nd ed. Marcel Dekker, New York.","DOI":"10.1201\/b14095"},{"key":"10.1016\/j.ejps.2004.03.007_BIB6","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1001\/archneur.1983.04210070043012","article-title":"Intracerebral hemorrhage and oral amphetamine","volume":"40","author":"Harrington","year":"1983","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.ejps.2004.03.007_BIB7","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/BF01070902","article-title":"Pharmacokinetics and tissue distribution of chlorpheniramine in rabbits after intravenous administration","volume":"9","author":"Huang","year":"1981","journal-title":"J. Pharmacokinet. Biopharm."},{"key":"10.1016\/j.ejps.2004.03.007_BIB8","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S1570-0232(03)00231-9","article-title":"HPLC studies on the pharmacokinetics of phentermine and fenfluramine in brain and blood microdialysates after intraperitoneal administration to rats","volume":"791","author":"Kaddoumi","year":"2003","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.ejps.2004.03.007_BIB9","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0731-7085(03)00633-2","article-title":"High performance liquid chromatography with fluorescence detection for the determination of phenylpropanolamine in human plasma and rat\u2019s blood and brain microdialysates using DIB-Cl as a label","volume":"34","author":"Kaddoumi","year":"2004","journal-title":"J. Pharmacol. Biomed. Anal."},{"key":"10.1016\/j.ejps.2004.03.007_BIB10","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1056\/NEJM200012213432501","article-title":"Phenylpropanolamine and the risk of hemorrhagic stroke","volume":"343","author":"Kernan","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejps.2004.03.007_BIB11","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0002-9343(90)90299-S","article-title":"Adverse drug effects attributed to phenylpropanolamine: a review of 142 case reports","volume":"89","author":"Lake","year":"1990","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ejps.2004.03.007_BIB12","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/clpt.1990.93","article-title":"Phenylpropanolamine increases plasma caffeine levels","volume":"47","author":"Lake","year":"1990","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2004.03.007_BIB13","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/0002-9343(89)90341-0","article-title":"Transient hypertension after two phenylpropanolamine diet aids and the effects of caffeine: a placebo-controlled follow-up study","volume":"86","author":"Lake","year":"1989","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ejps.2004.03.007_BIB14","unstructured":"Morgan, J.P., 1985. Over-the-counter medication: availability and issues. In: Morgan, J.P., Kagan, D.V., Brody, J.S. (Eds.), Phenylpropanolamine: Risks, Benefits, and Controversies. Praeger Publishers, New York, pp. 3\u201310."},{"key":"10.1016\/j.ejps.2004.03.007_BIB15","unstructured":"Morgan, J.P., 1986. Phenylpropanolamine: a critical analysis of reported adverse reactions and overdosage. Jack K. Burgess Inc., Fort Lee, NJ."},{"key":"10.1016\/j.ejps.2004.03.007_BIB16","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1161\/01.STR.15.1.119","article-title":"Cerebral hemorrhage associated with phenylpropanolamine in combination with caffeine","volume":"15","author":"Mueller","year":"1984","journal-title":"Stroke"},{"key":"10.1016\/j.ejps.2004.03.007_BIB17","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/bmc.186","article-title":"HPLC determination of phenylpropanolamine in pharmaceutical OTC preparations","volume":"16","author":"Nakashima","year":"2002","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.ejps.2004.03.007_BIB18","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1177\/106002808802200403","article-title":"A controlled clinical trial of the cardiovascular and psychological effects of phenylpropanolamine and caffeine","volume":"22","author":"Noble","year":"1988","journal-title":"Drug Intell. Clin. Pharm."},{"key":"10.1016\/j.ejps.2004.03.007_BIB19","unstructured":"Paxinos, G., Watson, C., 1986. The Rat Brain in Stereotaxic Coordinates, 2nd ed. Academic Press, San Diego. Phenylpropanolamine information page: http:\/\/www.fda.gov\/cdr\/drug\/infopage\/ppa."},{"key":"10.1016\/j.ejps.2004.03.007_BIB20","unstructured":"Physicians\u2019 Desk Reference, 2000. 54th ed. Medical Economics Data Co., Montvale, NJ."},{"key":"10.1016\/j.ejps.2004.03.007_BIB21","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1067\/mhl.2003.27","article-title":"Case report: dexatrim (phenylpropanolamine) as a cause of myocardial infraction","volume":"32","author":"Pilsczek","year":"2003","journal-title":"Heart Lung"},{"key":"10.1016\/j.ejps.2004.03.007_BIB22","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1515\/DMDI.1999.15.4.259","article-title":"Time dependent pharmacokinetic interaction between phenylpropanolamine and chlorpheniramine maleate in human subjects","volume":"15","author":"Rao","year":"1999","journal-title":"Drug Metab. Drug Interact."},{"key":"10.1016\/j.ejps.2004.03.007_BIB23","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0378-4274(02)00227-8","article-title":"Effects of xanthine derivatives on the influx and efflux of doxorubicin in P388 and DOX-resistant P388 leukemia cells","volume":"135","author":"Sadzuka","year":"2002","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.ejps.2004.03.007_BIB24","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1349-7006.1993.tb02877.x","article-title":"Caffeine modulates the antitumor activity and toxic side effects of adriamycin","volume":"84","author":"Sadzuka","year":"1993","journal-title":"Jpn. J. Cancer Res."},{"key":"10.1016\/j.ejps.2004.03.007_BIB25","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0378-4274(94)03154-Y","article-title":"Mechanism of caffeine modulation of the antitumor activity of adriamycin","volume":"75","author":"Sadzuka","year":"1995","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.ejps.2004.03.007_BIB26","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0304-3835(98)00375-9","article-title":"Enhanced efficacy of 1-methyl-3-propyl-7-butyxanthine on the antitumor activity of doxorubicin against doxorubicin-resistant P388 leukemia","volume":"138","author":"Sadzuka","year":"1999","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ejps.2004.03.007_BIB27","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0378-4274(99)00290-8","article-title":"Efficacies of tea components on doxorubicin induced antitumor activity and reversal of multidrug resistance","volume":"114","author":"Sadzuka","year":"2000","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.ejps.2004.03.007_BIB28","first-page":"572","article-title":"Caffeine potentiates phenylpropanolamine lethality but not motor behavior","volume":"43","author":"Schlemmer","year":"1984","journal-title":"Fed. Proc."},{"key":"10.1016\/j.ejps.2004.03.007_BIB29","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/j.1552-4604.1996.tb04758.x","article-title":"The pharmacokinetics and bioavailability of clemastine and phenylpropanolamine in single-component and combination formulations","volume":"36","author":"Schran","year":"1996","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2004.03.007_BIB30","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1016\/0024-3205(91)90487-V","article-title":"Drug distribution studies with microdialysis. II. Caffeine and theophylline in blood, brain and other tissues in rats","volume":"49","author":"Stahle","year":"1991","journal-title":"Life Sci."},{"key":"10.1016\/j.ejps.2004.03.007_BIB31","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1161\/01.STR.16.4.734","article-title":"Intracerebral hemorrhage and angiographic beading following ingestion of catecholaminergics","volume":"16","author":"Stoessl","year":"1985","journal-title":"Stroke"},{"key":"10.1016\/j.ejps.2004.03.007_BIB32","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1007\/BF02247122","article-title":"Drug interactions in the reinforcing effects of over-the-counter cough syrups","volume":"102","author":"Suzuki","year":"1990","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejps.2004.03.007_BIB33","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/0091-3057(86)90438-7","article-title":"The effect of antihistaminic drugs on pentazocine antinociception in the rat","volume":"24","author":"Yeh","year":"1986","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejps.2004.03.007_BIB34","first-page":"163","article-title":"Inhibition of monoamine oxidase activity by phenylpropanolamine, an anorectic agent","volume":"51","author":"Yu","year":"1986","journal-title":"Res. Commun. Chem. Pathol. Pharmacol."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098704000703?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098704000703?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,2]],"date-time":"2020-04-02T03:40:00Z","timestamp":1585798800000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098704000703"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,6]]},"references-count":34,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2004,6]]}},"alternative-id":["S0928098704000703"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2004.03.007","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2004,6]]}}}